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All retroviruses (except the spumaretroviruses) contain a nucleocapsid (NC) protein that encodes one or two copies of the
Zn21-finger sequence -Cys-X2-Cys-X4-His-X4-Cys-. This region has been shown to be essential for recognition and packaging
of the genomic RNA during virion particle assembly. Additionally, this region has been shown to be involved in early infection
events in a wide spectrum of retroviruses, including mammalian type C [e.g., murine leukemia virus (MuLV)], human
immunodeficiency virus type 1 (HIV-1), Rous sarcoma virus, and other retroviruses. Mutations in the two Zn21-fingers of the
NC protein of simian immunodeficiency virus strain Mne [SIV(Mne)] have been generated. The resulting virions contained the
normal complement of processed viral proteins with densities indistinguishable from wild-type SIV(Mne). All of the mutants
had electron micrograph morphologies similar to those of immature particles observed in wild-type preparations. RNA
packaging was less affected by mutations in the NC protein of SIV(Mne) than has been observed for similar mutants in the
MuLV and HIV-1 systems. Nevertheless, in vitro replication of SIV(Mne) NC mutants was impaired to levels comparable to
those observed for MuLV and HIV-1 NC mutants; replication defective NC mutants are typically 105- to 106-fold less infectious
than similar levels of wild-type virus. One mutant, DCys33–Cys36, was also found to be noninfectious in vivo when mutant
virus was administered intravenously to a pig-tailed macaque. NC mutations can therefore be used to generate replication
defective virions for candidate vaccines in the SIV macaque model for primate lentiviral diseases.
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DINTRODUCTION
One of the most highly conserved sequence elements
f retroviruses is the Zn21-finger, which is contained in
he nucleocapsid (NC) domain of the Gag precursor. It is
ommon to all retroviruses except the spumaretroviruses
Maurer et al., 1988). This element is found once or twice
epending on the particular virus and consists of a 14-
mino-acid sequence of invariantly spaced Cys and His
esidues: -Cys-X2-Cys-X4-His-X4-Cys- (Berg, 1986; Covey,
986). The ligand binding residues (Cys and His) are
xquisitely sensitive to alterations. When these amino
cids are mutated to nonZn21 binding residues, the
tructure is unable to bind Zn21 tightly and therefore
endered inactive (Casas-Finet et al., 1997a; 1997b).
hrough mutagenesis and structural (DeGuzman et al.,
998) studies, retroviral NC Zn21-finger structures in the
ag precursor have been implicated in genomic RNA
ackaging. Nonconservative mutations in the Zn21-
inger motifs of avian, murine, and human retroviral NC
roteins that abrogate Zn21 binding results in the pro-
The contents of this publication do not necessarily reflect the views
r policies of the DHHS, nor does mention of trade names, commercial
roducts, or organizations imply endorsement by the U.S. Government
1 To whom reprint requests should be addressed at Fax: (301) 846-
e119, E-mail: gorelick@avpaxp1.ncifcrf.gov
259uction of mainly RNA-deficient, noninfectious virions
Aldovini and Young, 1990; Dorfman et al., 1993; Dupraz et
l., 1990; Gorelick et al., 1988, 1990; Meric et al., 1988;
akalian et al., 1994). In addition to the well established
ole in viral packaging, more recent studies have clearly
hown that the structure of NC Zn21-fingers present in
he mature NC protein function in early infection events
Gorelick et al., 1996; Tanchou et al., 1998).
It was of interest to compare NC mutants of simian
mmunodeficiency virus (SIV) to determine whether they
ere phenotypically similar to NC mutants in the human
mmunodeficiency virus type 1 (HIV-1) and Moloney murine
eukemia virus (Mo-MuLV) systems. It is possible that SIV
C mutant particles could serve as effective immunogens
n vaccine studies using the SIV/macaque animal model.
his report describes the preparation and characterization
f a number of NC protein Zn21-finger mutants that were
onstructed on the genetic backbone of SIV(Mne), a patho-
enic strain of SIV isolated and cloned from a pig-tailed
acaque (Macaca nemestrina) (Benveniste et al., 1990,
986; Heidecker et al., 1998).
The phenotypes of SIV(Mne) NC mutants described
ere were similar to those previously reported for NC
n21-finger mutants of HIV-1 (Aldovini and Young, 1990;
orfman et al., 1993; Gorelick et al., 1990), with the
xception of somewhat higher RNA levels in a number of
0042-6822/99
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260 GORELICK ET AL.he SIV(Mne) mutants examined. In addition, one mutant
irus (DCys33–Cys36) was found not to be detectably
nfectious after in vivo inoculation of a pig-tailed ma-
aque. Proviruses with mutations in the gene coding for
C that render progeny viruses noninfectious may pro-
ide a promising novel approach for vaccine develop-
ent. Particles produced from such mutant proviral
lones assemble and bud from the surface of the cell in
manner similar to wild-type virus. Authentic, conforma-
ionally intact viral structures thus can be presented to
he immune system in a setting devoid of the risk of
preading infection.
RESULTS
iral protein analyses of mutant and wild-type
IV(Mne) viruses
The mutations introduced into the full-length proviral
lone of SIV(Mne) clone 8 (Benveniste et al., 1990;
eidecker et al., 1998) in the gene coding for the NC
rotein are summarized in Fig. 1. Mutant and wild-type
roviruses were introduced into the vector, pSVori/
eo. When transfected into 293T or 293 cells (adeno-
irus transformed human fetal kidney cells with or
ithout expression of the large T antigen, respec-
ively), the clones transiently expressed virus parti-
les. Mutant and wild-type viruses from cells trans-
ected with the proviral plasmids listed in Table 1 were
sed in this study.
Table 1 also lists reverse transcriptase (RT) activities
nd p28CA levels of mutant and wild-type viruses ob-
ained after a typical transfection. Samples were ad-
usted to equal levels of RT activity and fractionated by
DS–PAGE. Immunoblot analysis revealed the presence
f similar levels of processed p28CA protein (Fig. 2A).
nvelope proteins were also observed at comparable
evels in mutant and wild-type preparations (Fig. 2B).
aken together, the immunoblot, p28CA ELISA, and RT
nalyses roughly show that gag-to-pol as well as env-to-
ol gene product ratios were comparable between the
FIG. 1. Mutations introduced into the NC protein of SIV(Mne). Lines
equence. Abbreviations are as follows: C25S, Cys253Ser; C36S, C
rp133Gly; W34G, Trp343Gly; DC12–C15, DCys12–Cys15 (mutation res
Cys33–Cys36 (mutation deletes amino acid residues Cys, Trp, Lys, an
rg-Glu-Gly linker, and the second Zn21-finger are deleted). Positions
enderson et al. (1988) and are indicated at the top of the figure.utant and wild-type viruses. These data also indicate vhat the pol gene products RT and protease (PR) are
unctional in the mutant viruses. Some uncleaved pre-
ursor species that react with the p28CA monoclonal
ntibody were observed in several of the mutants (Fig.
A), suggesting incomplete processing of the Gag pre-
ursor by the viral PR in most of the mutants but not the
ild-type or Gly403Asp mutant viruses.
NA blot analysis of transiently expressed mutant
nd wild-type virus particles from 293T cells
Mutant and wild-type SIV particles were prepared
nd analyzed for full-length SIV genomic RNA using a
andom primed 32P-labeled 8.2-kbp DraIII–BglI
IV(Mne) probe (Fig. 3). Samples were adjusted for
qual RT levels, fractionated by formaldehyde–
garose gel electrophoresis, and analyzed as de-
te amino acid residues that are the same as those in the wild-type
Ser; G19D, Gly193Asp; G40D, Gly403Asp; P9E/W13G, Pro93Glu/
the deletion of amino acid residues Cys, Trp, Asn, and Cys); DC33–C36,
; DC12–C46, DCys12–Cys46 (the first Zn21-finger, the Arg-Thr-Pro-Arg-
amino acids in the mature, wild-type SIV(Mne) NC protein are from
TABLE 1
Properties of Mutant and Wild-Type SIV(Mne) Particles
Mutation
Plasmid
designation
RT activitya
(cpm/ml)
3 106
p28CA
(mg/mL)b
2) Controlc 0d 0
ild type pRB86 6.55 1.50
ys25 3 Ser pRB119 4.61 2.55
ys36 3 Ser pRB121 3.96 1.70
ly19 3 Asp pRB123 4.28 1.19
ly40 3 Asp pRB124 6.74 3.03
ro9 3 Glu/Trp13 3 Gly pRB127 2.83 1.38
rp34 3 Gly pRB128 3.44 0.95
Cys12-Cys15 pRB129 1.85 0.62
Cys33-Cys36 pRB130 1.48 0.76
Cys12-Cys46 pRB131 0.44 0.25
a RT activity is expressed as cpm of [3H]TMP incorporated per mil-
iliter of culture fluid.
b Determined using the Retro-Tek SIV-1 Antigen ELISA from Cellular
roducts, Inc. (Buffalo, NY).
c Samples from 293T cells transfected with sheared salmon sperm
NA.
d A background of 1623 cpm/ml has been subtracted from the RTindica
ys363
ults in
d Cys)
of thealues shown.
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261SIV(Mne) NC Zn21-FINGER MUTANTScribed previously (Gorelick et al., 1996). The
ys253Ser, DCys33–Cys 36, and DCys12–Cys46 mu-
ants packaged less than wild-type levels of full-length
iral RNA. For comparison, HIV-1 NC mutants in which
igand binding residues were replaced with Ser had
reatly reduced levels of full-length viral RNA (Aldovini
nd Young, 1990; Dorfman et al., 1993; Gorelick et al.,
990); they packaged ,20% wild-type levels of their
enomes. All other mutants in this study reproducibly
ackaged levels of full-length genomic RNA that were
omparable to or greater than that for the wild-type
irus. Note that it has been shown previously that the
ajority of the smeared material that hybridizes with
he 32P-radiolabeled probe is degraded DNA from the
riginal transfection. This degraded DNA copurifies
FIG. 2. Protein immunoblot analysis of wild-type and mutant
IV(Mne) virus particles transiently expressed in 293T cells. Clarified
upernatants were centrifuged at 120,000g for 1 h at 4°C. Samples
ere adjusted for equal RT levels, fractionated by SDS–PAGE, and
reated as described under Materials and Methods. (A) Immunoblot
sing 4.6 3 106 cpm RT activity of mutant and wild-type virus, visualized
sing mouse monoclonal antibody against p28CA [AIDS Vaccine Pro-
ram, Biological Products Laboratory (AVP-BPL) inventory no. 96–0020
9A P9B5 H8B1]. (B) Immunoblot using 4.0 3 106 cpm of RT activity of
utant and wild-type virus, detected with polyclonal rabbit antiserum
gainst gp120SU (AVP-BPL inventory no. DJ-36603 OD3545). Marker
roteins are indicated on the left, and positions of (A) p28CA, Pr55Gag,
nd (B) gp120SU are indicated on the right of each panel. (2) Control
nd WT indicate pellets from centrifuged supernatants from 293T cells
ransfected with sheared salmon sperm and wild-type SIV(Mne) DNA,
(espectively.ith the particles and results in the contamination of
he RNA sample (Gorelick et al. 1996).
eal-time RT-PCR determination of RNA content of
utant and wild-type viruses
Viral RNA levels were also determined by real time
T-PCR as described previously (Suryanarayana et al.,
998). RNA samples were prepared from mutant and
ild-type viral pellets as described under Materials
nd Methods. DNase treatment of all samples was
equired before RT-PCR to remove contaminating DNA.
he majority of the DNA observed in the samples
robably originated from the proviral plasmid clones
sed in the transfections to obtain the viral particles.
able 2 summarizes the levels of viral RNA contained
n the mutants. The Cys363Ser, DCys33–Cys36, and
Cys12–Cys46 mutants were found to contain less
han wild-type levels of genomic RNA. All other mu-
ants packaged viral RNA at levels comparable to or
reater than wild-type levels.
lectron micrograph analysis
Transfected 293T cells produced abundant levels of
utant and wild-type SIV(Mne) particles. Thin sections
f cells transfected with proviral clones were exam-
ned at a magnification of 90,0003. Electron micro-
raphs from wild-type SIV(Mne), as well as the
ys363Ser and DCys12–Cys46 mutants, are given
FIG. 3. RNA blot analysis of wild-type and mutant SIV(Mne) virus
articles transiently expressed in 293T cells. Particles were analyzed
or full-length SIV(Mne) genomic RNA using a 32P-labeled 8.2-kbp
raIII–BglI SIV(Mne) probe. All samples were adjusted for equal RT
evels (7.9 3 105 cpm), fractionated, and treated as described under
aterials and Methods. Dilutions (10- and 100-fold) of the wild-type
ample were also tested. (2) Control indicates samples isolated and
repared from centrifuged supernatants from 293T cells transfected
ith sheared salmon sperm DNA. The RNA markers are indicated on
he left, and the size of full-length SIV(Mne) genomic RNA is noted on
he right.see Fig. 5). Wild-type virus preparations contain uni-
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262 GORELICK ET AL.ormly sized particles of ;100 nm in diameter. In
ddition, both mature and immature particles are evi-
ent (see Fig. 5A) with ;30% of the particles being of
mature morphology. The Gly403Asp mutant prepa-
ations also contained mature particles because it
as replication competent (see below); ;20% of the
ly403Asp particles were of a mature morphology. All
f the mutant clones (except Gly403Asp and DCys12–
ys46) produced particles that had predominantly the
mmature morphology. An example of the mutant par-
icles is shown (see Fig. 5B). These particles are
erived from 293T cells transfected with the
ys363Ser proviral clone. All mutant particles (except
he DCys12–Cys46 particles) are uniform in diameter
;100 nm) and had morphologies identical to those of
ys363Ser particles. Well defined spikes are easily
isualized on the surface of all of the mutant and
ild-type particles, identical to those seen (see Figs.
A and 5B). Presumably, these are the SIV envelope
lycoproteins gp120SU. These structures were not as
ell defined in transmission electron micrographs of
IV-1 NC mutant or wild-type particles (Gorelick et al.,
993). The DCys12–Cys46 mutant particles are shown
see Fig. 5C). These particles are highly variable in
oth diameter and shape, with a majority of the parti-
les being larger than normal. In addition, the outer
ing of electron dense material appears to be less
iffuse in the DCys12–Cys46 particle compared with
he outer ring seen in the immature particles from the
ther mutant and wild-type particles. It should be
oted that the densities of all viruses examined in this
T
Relative RNA Content of Viruses Derived from Transfec
Mutation
RT adjusted
RNA
contenta nb
2) Controld 0
ild type 100
ys25 3 Ser 96 3
ys36 3 Ser 73 3
ly19 3 Asp 189 3
ly40 3 Asp 62 2
ro9 3 Glu/Trp13 3 Gly 109 2
rp34 3 Gly 77 3
Cys12-Cys15 96 2
Cys33-Cys36 39 2
Cys12-Cys46 8 3
a Nominal RNA copies/ml of culture supernatant were determined by
f culture fluid was then divided by either the RT activity or p28CA con
ercent wild-type level of RNA in the mutants was then calculated by d
he wild-type virus and then multiplying by 100.
b n 5 number of samples examined.
c Standard error 5 standard of the mean.
d (2) Control 5 samples isolated, prepared and analyzed from 293Tork were 1.16 6 0.02 g/ml as determined by isopycnic wucrose density gradient centrifugation (data not
hown), performed as described previously (Gorelick
t al., 1988).
nfectivity analyses of mutant and wild-type virus
Supernatants containing mutant or wild-type virus
rom 293T transfections were clarified and used to infect
A2-clone 5 cells. Supernatants were harvested weekly,
nd RT activity was measured. Figure 4A shows the
esults of an 8-week cultivation of mutant and wild-type
IV. All of the mutants were replication defective except
or Gly403Asp. The titers of the wild-type and the repli-
ation competent mutant viruses were determined by
0-fold limiting serial dilutions (Figs. 4B and 4C, respec-
ively). The Gly403Asp mutant was infectious at a dilu-
ion of 1:104 but not at a dilution of 1:105. Wild-type virus
btained by transfection could infect the AA2-clone 5
ulture at a dilution of 1:105 but not at a dilution of 1:106.
n vivo infectivity analysis of SIV(Mne)-DCys33–Cys36
The mutant DCys33–Cys36 virus was injected intrave-
ously into a juvenile pig-tailed macaque (Washington
egional Primate Research Center, Seattle, WA; animal
dentification number M91182) to determine whether an
IV(Mne) NC mutant was infectious in an animal from
hich the wild-type virus was originally obtained. The
tock of the noninfectious SIV(Mne) DCys33–Cys36 mu-
ant injected into a macaque contained 28 mg of p28CA,
he equivalent of an infectious stock with a titer of ;1.4 3
07 AID, had this virus actually been infectious. An AID
ith Wild-Type or NC Mutant SIV(Mne) Proviral Clones
p28CA adjusted
tandard
errorc
RNA
contenta nb
Standard
errorc
0
100
52 82 2 27
45 42 2 26
31 251 2 111
41 65 2 3
22 122 1
19 87 2 17
5 106 1
4 54 1
4 14 2 5
e RT-PCR (Suryanarayana et al., 1998). The RNA copy number per ml
r ml of culture fluid for the same sample for each of the mutants. The
this parameter for the mutants by the same parameter calculated for
ransfected with sheared salmon sperm DNA.ABLE 2
tions w
S
real-tim
tent pe
ividingas determined previously by titering SIV(Mne) viral
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dilution analysis. Dilutions are 1:107 (f), 1:106 (), 1:105 (F), 1:104 (), 1:103
263SIV(Mne) NC Zn21-FINGER MUTANTStocks in three species of macaques (Benveniste et al.,
994; Kuller et al., 1994; Tsai et al., 1993). The infectious
iter of these stocks in vivo range from 104 to 105 AID/ml.
ecause these stocks typically contain 20–200 ng/ml
28CA, an animal infectious dose corresponds to ;2 pg
f p28CA.
Longitudinal samples were analyzed over a period of
18 weeks postinoculation, after which the animal was
uthanized. At no time could virus be isolated from 8 3
06 PBMC that were analyzed at each sampling, nor
ould SIV proviral sequences be detected by the sensi-
ive nested PCR method (Benveniste et al., 1988; 1994).
y nested PCR, proviruses could not be detected in
nguinal, axillary, or mesenteric lymph nodes or in spleen
issue obtained at necropsy, nor could proviruses be
etected by nested PCR in PBMC obtained at various
imes after inoculation. The animal did not develop any
easurable antibodies to SIV viral proteins and was
linically normal when euthanized.
DISCUSSION
At this laboratory, we are currently using the SIV/
acaque model to examine candidate vaccines against
mmunodeficiency viruses and are exploring a novel vac-
ine approach. It was therefore of interest to characterize
he behavior of SIV NC mutants, particularly in relation to
reviously described HIV-1 and MuLV NC mutants. The
henotypes of the SIV(Mne) NC mutants described in
his study are in fact reminiscent of those for similar
o-MuLV and HIV-1 mutants. Transfected mutant clones
ransiently produced virions that were replication defec-
ive (except for the Gly403Asp mutant) and, in a number
f cases, viral RNA deficient. Comparable exogenous
emplate RT activities were observed in mutant and wild-
ype virions (Table 1). Protein expression and processing
n the mutants were also similar to those of wild-type
irus (Fig. 2). The presence of uncleaved precursors in
he mutant virus preparations is probably due to de-
reased processing efficiency related to changes in the
onformation of the Gag precursor rather than to a de-
rease in the activity of the viral PR protein. The DCys12–
ys46 mutant has less of a Gag precursor processing
efect than the other mutants. This phenotype resembles
hat observed for a similar mutant, the RSV Myr1.DNC
utant reported by Krishna et al. (1998). Additionally, the
ly403Asp mutant does not show processing defects;
his mutant is replication competent. In contrast to sim-
lar HIV-1 and Mo-MuLV mutants that produce RNA-
eficient virions, a number of the SIV(Mne) NC mutants
ackage greater quantities of viral RNA.
This report, to our knowledge, presents the first char-
L), 1:102 (M), 1:101 (), and undilute (E). (C) Infectious titer of
ly403Asp mutant. Virus was diluted as follows: 1:106 (), 1:105 (F),FIG. 4. Infectivity analysis of mutant and wild-type SIV(Mne) viruses in
A2-clone 5 cells. Mutant and wild-type viruses were used to infect
A2-clone 5 cells. RT activities, corrected for background (in cpm [3H]TMP
ncorporated/ml) of starting inoculum, are as follows: negative control
AA2-clone 5 cells infected with clarified supernatants from 293T cells
ransfected with sheared salmon sperm DNA), 0 cpm; Cys253Ser, 9.6 3
05 cpm; Cys363Ser, 5.3 3 105 cpm; Gly193Asp, 9.2 3 105 cpm;
ly403Asp, 2.1 3 106 cpm; Pro93Glu/Trp133Gly, 6.9 3 105 cpm;
rp343Gly, 1.3 3 106 cpm; DCys12–Cys15, 6.7 3 105 cpm; DCys33–Cys36,
.2 3 105 cpm; DCys12–Cys46, 6.3 3 105 cpm; and wild-type SIV(Mne),
.7 3 106 cpm. (A) Undilute SIV(Mne) mutant and wild-type viruses. Sym-
ols are as follows: negative control (l), Cys253Ser (f), Cys363Ser (),
ly193Asp (F), Gly403Asp (), Pro93Glu/Trp 133Gly (), Trp343Gly
L), DCys12–Cys15 (M), DCys33–Cys36 (), DCys12–Cys46 (E), and wild-
ype SIV(Mne) (circle with left half filled). (B) Wild-type SIV(Mne) end point:104 (), 1:103 (L), 1:102 (M), 1:101 (), and undilute (E).
264 GORELICK ET AL.
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265SIV(Mne) NC Zn21-FINGER MUTANTScterization of the full-length genomic RNA content of an
IV preparation. The Cys363Ser, DCys33–Cys36, and
Cys12–Cys46 mutants of SIV(Mne) packaged reduced
evels of full-length genomes as assessed by Northern
lot (Fig. 3), and this reduction was also observed when
iral RNA content was measured by real-time RT-PCR
Suryanarayana et al., 1998). For these three mutants,
his result was similar to results obtained with other
etroviral NC mutants that alter ligand-binding residues
o non-Zn21-coordinating residues (e.g., changes in
n21-binding residues to those other than Cys or His or
hat delete part or all of the Zn21-finger; Aldovini and
oung, 1990; Dorfman et al., 1993; Dupraz et al., 1990;
orelick et al., 1988, 1990; Meric et al., 1988).
It is surprising that a number of mutants that were
eplication defective were found to contain viral RNA
evels comparable to or greater than levels found in the
ild-type virus. This suggests that the NC domain of
IV(Mne) is not as sensitive to alteration with respect to
enomic RNA packaging as are HIV-1 or MuLV. In addi-
ion, there is agreement between the Northern blot anal-
sis that examines full-length viral RNA genomes and the
FIG. 5. Electron micrographic analysis of mutant and wild-type SIV
roviral clones. At 48 h after transfecting, cells were fixed in glutaraldeh
ere visualized at 90,0003, and the distance corresponding to 100 nm
articles from transfected 293T cells. Mature and immature particles
ys363Ser proviral DNA clone. (C) 293T cells expressing DCys12–Cyeal-time RT-PCR method that samples total viral RNA ifull-length as well as degraded RNA) containing the
arget gag sequence (Suryanarayana et al., 1998) in the
irions. This reinforces the conclusion that mutations in
he NC domain of the Gag precursor actually affect
enome packaging (Aldovini and Young, 1990; Dorfman
t al., 1993; Dupraz et al., 1990; Gorelick et al., 1988, 1990;
eric et al., 1988; Rein et al., 1994; Sakalian et al., 1994)
s opposed to altering protection of the viral RNA by the
C protein (Aronoff et al., 1993).
An interesting observation was made regarding the
ffinity of SIV(Mne) core proteins for the viral RNA ge-
ome. Although viral RNA can be isolated from Mo-MuLV
r HIV-1 by treatment of virus with 1% SDS and subse-
uent phenol extraction (Gorelick et al., 1993, 1988, 1990),
t cannot be isolated from SIV(Mne) mutant or wild-type
iruses by this method as was previously observed (Ben-
eniste et al., 1986). A Proteinase K digestion step (Fu et
l., 1994; Fu and Rein, 1993; Stewart et al., 1990) is
equired with SIV(Mne), after which viral RNA can readily
e isolated from particles after phenol–chloroform ex-
raction. This indicates that there is a very tight associ-
tion of SIV viral core proteins with the RNA genome that
articles. The 293T cells were transfected with mutant and wild-type
d prepared for thin section transmission electron microscopy. Particles
icated in the lower left corner of each panel. (A) Wild-type SIV(Mne)
noted in the figure. (B) Particles from 293T cells transfected with the
tant particles.(Mne) p
yde an
is ind
are des not disrupted by the addition of SDS alone. When SIV
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266 GORELICK ET AL.reparations were treated only with SDS and then ex-
racted with phenol–chloroform, the RNA partitioned in
he organic layer with tightly bound viral proteins.
Due to the tight interaction between the viral core
roteins and the viral RNA, additional properties of the
utant and wild-type SIV particles were examined. How-
ver, there were no surprising results when the densities
f these particles were determined by equilibrium den-
ity gradient centrifugation on 10–50% isopycnic sucrose
radients (data not shown). Additionally, electron micro-
raphs of mutant and wild-type particles (Figs. 5A and
B) were not out of the ordinary, except for the DCys12–
ys46 mutant. The mutant and wild-type particles were
niform in diameter with replication competent viruses
Gly403Asp and wild-type SIV(Mne)], having mature and
mmature morphologies, and the mutant viruses showed
ainly immature morphologies.
The SIV(Mne) DCys12–Cys46 particles were interest-
ng because they had a normal density but were larger in
ize and had irregular shapes, as seen in Fig. 5C. This
henotype is similar to the M1.HNCD mutant reported by
arnier et al. (1998). The M1.HNCD clone produced par-
icles of normal density but were larger in size as deter-
ined by velocity gradient centrifugation. It appears that
he mutation introduced into the SIV(Mne) DCys12–
ys46 mutant altered a particle size determinant, as had
he mutation introduced into the M1.HNCD particles that
emoved the carboxyl-terminal half of the NC sequence
including the second Zn21-finger) and the first four res-
dues of the spacer peptide SP2 (Garnier et al., 1998).
The infectious titers of the SIV(Mne) mutants are
eminiscent of similar MuLV and HIV-1 NC mutants
Fig. 4A). All mutations appear to render SIV(Mne)
articles replication defective with one exception. The
ly403Asp mutation has a titer of 104 tissue culture
nfectious doses (TCID)/ml (Fig. 4C). This mutant was
onstructed and examined because several SIV provi-
al clones have an Asp residue replacing the con-
erved Gly residue adjacent to the conserved His in
he second Zn21-finger of SIV NC (e.g., SIV strains
m251, Mm32H, Mm1A11, Mm239, and Mm142; Korber
t al., 1997). We wished to see if there was any detri-
ent to replication if the Gly adjacent to the conserved
is in either the first or second position finger (amino
cid residue 19 and 40, respectively; Fig. 1) was re-
laced with Asp. Like the SIV strains with the Gly-to-
sp change, the distal finger of SIV(Mne) can accom-
odate such a change, whereas the finger in the first
osition cannot. This suggests that for SIV(Mne), al-
erations in the finger in the first position are less
olerant of alteration than the second position finger
ith respect to preservation of viral replication, as was
bserved with the HIV-1 NC Zn21-finger mutants re-
orted by Gorelick et al. (1990). In the pNC1/1, pNC2/1,
nd pNC2/2 mutants of HIV-1, only those that con-
ained the first position NC Zn21-finger amino acid
equence in the first NC Zn21-finger position were ieplication competent to varying degrees [e.g.,
NL4–3 (wild-type HIV-1) and pNC1/1 (Gorelick et al.
993)]. Figure 4B shows that wild-type SIV(Mne) had a
iter of 105 TCID/ml. Even though the mutant particles
ere able to package significant levels of full-length
enomic RNA in some cases, a significant defect in
eplication was nonetheless evident because they
ere $105-fold less infectious than wild-type virus. A
imilar phenotype was observed in the His233Cys
nd Cys343His mutants of MuLV. Both mutants pack-
ged wild-type levels of full-length genomic
NA but were nonetheless replication defective (Gorelick
t al., 1996). These results parallel previous observations
hat additional functions are performed by the retroviral
C protein, beyond its well established role in genomic
NA recognition and packaging (Gorelick et al., 1988,
990, 1996; Poon et al., 1996, 1998; Tanchou et al., 1998).
t should also be noted that there is a strong correlation
etween mutants that are replication defective and those
hat show incomplete processing of the Gag precursor
Fig. 2A). This suggests that the replication defect may be
ttributable in part to changes in the conformation of the
ature viral core.
SIV(Mne) DCys33–Cys36 mutant virus particles were
lso inoculated into a pig-tailed macaque to examine in
ivo infectivity. The animal did not become infected as
etermined by virus isolation (Benveniste et al., 1988),
ested PCR procedures (Benveniste et al., 1994), or the
evelopment of antibodies to SIV proteins, despite intra-
enous inoculation with the equivalent of 1.4 3 107 AID.
dose of 1.4 3 107 AID of wild-type SIV(Mne) virus would
ertainly result in the productive infection of a macaque.
he infectivity results in this study parallel results from
imilar mutants in HIV-1 (Aldovini and Young, 1990; Dorf-
an et al., 1993; Gorelick et al., 1990). Alterations to the
C Zn21-fingers of these viruses, especially the ligand-
inding residues, result in virions that are replication
efective and do not revert over extended culture periods
r, as shown in this work, do not revert in an animal. In
ddition, the DCys33–Cys36 NC mutant of SIV(Mne),
hich is noninfectious in vitro and in vivo but produces
ild-type levels of viral proteins, could be a potentially
aluable immunogen for vaccine studies.
MATERIALS AND METHODS
ell lines
The 293 cells (adenovirus-transformed human embry-
nic kidney cells) were obtained from American Type
ulture Collection (Rockville, MD). These cells were cul-
ured in minimal essential medium with Earle’s salts
E-MEM), containing 10% heat-inactivated fetal bovine
erum. The 293 cells, which express the large T antigen
293T), were obtained and cultured as described previ-
usly (Gorelick et al., 1996). This line was maintained in
ulbecco’s modified Eagle’s medium (E-MEM) contain-ng 2 mM l-glutamine and 10% heat-inactivated fetal
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267SIV(Mne) NC Zn21-FINGER MUTANTSovine serum. AA2-clone 5 cells were cultured in RPMI
640 medium containing 2 mM l-glutamine, 10% heat-
nactivated bovine calf serum, and 2 mg/ml hexad-
methrine bromide (Polybrene; Sigma Chemical Co., St.
ouis, MO). The AA2-clone 5 line is very sensitive to
IV-1 and SIV infection. AA2-clone 5 is a single cell clone
eveloped in the laboratory of R. Benveniste that is
erived from the AA2 cell line (American Type Culture
ollection) that is an EBV1 B lymphoblastoid cell line
ontaining high levels of CD4 (Chaffee et al., 1988). All
ell lines were maintained in an atmosphere of 7% CO2
t 37°C.
lasmids and mutagenesis
SIV(Mne), originally isolated from a pig-tailed ma-
aque with lymphoma, was cultured on HuT 78 cells
Benveniste et al., 1986). A single cell clone of infected
uT 78 cells, E11S, was used as the source of DNA to
btain the full-length proviral clone, SIV(Mne) clone 8
Benveniste et al., 1990; Heidecker et al., 1998). Clone 8
s flanked on both the 39 and 59 ends by ;1 kbp of
ncharacterized cellular DNA from HuT 78 cells. Each
lanking region contains a SalI restriction endonuclease
ite. SIV(Mne) clone 8 was used for constructing the
utant and wild-type full-length proviral plasmids de-
cribed below.
Site-directed mutagenesis was performed on a sub-
lone (designated pPP1) containing the SIV(Mne)
998-bp KpnI fragment [nucleotide (nt) positions 418–
416] cloned into the pBluescript KS(2) [pBSKS(2)] plas-
id (Stratagene, La Jolla, CA). Nucleotide positions refer
o the position in the SIV(Mne) provirus (Benveniste et al.,
990; Heidecker et al., 1998; GenBank Accession No.
32741). The following mutagenic oligonucleotides were
btained from Marilyn Powers of the DNA Support Lab-
ratory to ABL-Basic Research Program [SAIC-Frederick,
ational Cancer Institute–Frederick Cancer Research
nd Development Center (NCI–FCRDC)] and were used
o mutate the gene for the SIV(Mne) NC protein:
SL2512, 59-CAC TCT GCA AGG CAA TCC AGA-39
Cys253Ser, 59 end corresponds to nt 1733); OSL2514,
9-GGC TGC TGG AAA AGT GGA CAA-39 (Cys363Ser, 59
nd corresponds to nt 1769); OSL2695, 59-AAT TGT GGG
AA GAA GAC CAC-39 (Gly193Asp, 59 end corresponds
o nt 1715); OSL2516, 59-AAA TGT GGA CAA ATG GAC
AT-39 (Gly403Asp, 59 end corresponds to nt 1778);
SL2735, 59-AAG CAA ATT AAG TGT GGG AAT-39
Pro93Glu/Trp133Gly, 59 end corresponds to nt 1697);
SL2736, 59-AGA AGA CAG GGC TGC GGG AAA-39
Trp343Gly, 59 end corresponds to nt 1760); OSL3124,
9-CCA AGA AAG CCA ATT AAG GGG AAA GAG GGA
AC TCT-39 (DCys12–Cys15, 59 end corresponds to nt
691, nt 1709–1720 deleted); OSL3123, 59-ACC CCA AGA
GA CAG GGC GGA CAA ATG GGC CAT GTT-39
DCys33–Cys36, 59 end corresponds to nt 1754, nt 1772–
783 deleted); and OSL3125, 59-CCA AGA AAG CCA ATT wAG CCA GAC AGA CAG GCA GGT-39 (DCys12–Cys46,
9 end corresponds to nt 1691, nt 1709–1813 deleted). The
mino acid residue numbers refer to positions in the
ature SIV(Mne) NC protein (Henderson et al., 1988),
nd the underlined nucleotides indicate the changes in
he oligonucleotide sequences used to introduce point
utations in the NC gene.
The oligonucleotides were used in conjunction with
he Amersham Oligonucleotide-Directed In Vitro Mu-
agenesis System, Version 2 (Arlington Heights, IL). Once
utations were verified by sequencing of the pPP1 plas-
ids, BamHI–NsiI fragments (wild-type fragment is 561
p and corresponds to nt position 1329–1886) were
loned into the corresponding sites of a subclone des-
gnated pPP4. The plasmid pPP4 with the fragment from
he wild-type provirus contains a 3898-bp BamHI–SacI
ragment (nt position 1329–5223) cloned into pBKS(2).
he resulting BamHI–SacI fragments containing the var-
ous mutations were then ligated into homologous sites
f the original l-phage EMBL3 clone containing the
IV(Mne) clone 8 provirus.
For ease in the production of proviral DNA, the SalI
ragments containing mutant and wild-type full-length
IV(Mne) proviruses were transferred from the l-phage
MBL3 clones into a pBR322-based vector designated pS-
ori/neo. This vector was constructed as follows. To obtain
he SV40 origin of replication, a 2.0-kbp PvuII fragment from
V40 viral DNA was ligated using EcoRI linkers into the
coRI site of pBR322. pSVori was constructed by ligating
he resulting 342-bp EcoRI–HindIII fragment, containing the
V40 origin of replication from this last construct, into the
omologous sites of pBR322. A 2.2-kbp HindIII–BamHI frag-
ent containing the neo gene from pSV2neo (Southern and
erg, 1982) was cloned into the HindIII and BamHI sites of
SVori, next to the SV40 origin of replication, to create the
ector pSVori/neo. The mutant and wild-type clones used
or transfections were constructed by ligating the SalI frag-
ent of the full-length SIV(Mne) clone 8 proviruses from
he l-phage EMBL3 vector into the single SalI site of pS-
ori/neo. The resulting plasmid designations are listed in
able 1.
ransfections
The 293 cell line (without the large T-antigen) was
ransfected with the pRB130 clone (DCys33–Cys36 mu-
ant) using Lipofectin reagent (Life Technologies, Gaith-
rsburg, MD). To obtain a large quantity of the mutant
irus, 50% confluent monolayers in 150-cm2 flasks were
insed twice with 10 ml of Hanks’ balanced salt solution.
hen, 20 mg of DNA diluted to 8.0 ml with OptiMEM (Life
echnologies) was added to each monolayer and incu-
ated at room temperature for 30 min. Next, 75 ml of
ipofectin reagent (Life Technologies) diluted to 2.0 ml
ith OptiMEM was added to the monolayer (without
emoval of the DNA–OptiMEM solution), and the mixture
as incubated overnight at 37°C in a 7% CO2 atmo-
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268 GORELICK ET AL.phere. The next day, culture fluids were changed to 30
l of E-MEM containing 10% fetal bovine serum and
ncubated at 37°C. At 48 h later, the cell culture fluid was
emoved, and virus was harvested. Next, 30 ml of me-
ium was added to the cell monolayers, and they were
ncubated for an additional 48 h at 37°C. Culture fluids
ere again harvested, and virus was isolated. The tran-
iently expressed virus from each harvest was clarified
y centrifugation and purified as described previously
Bess et al., 1992). The DCys33–Cys36 mutant virus prep-
ration was used for intravenous injection of a macaque
s described below.
For viral particle analysis, mutant and wild-type provi-
al clones were transfected using the Calcium Phos-
hate Mammalian Cell Transfection Kit from 5 Prime-3
rime (Boulder, CO). Log phase 293T cells, grown in
50-cm2 flasks, were transfected, and virus was har-
ested as described previously (Gorelick et al., 1996).
riefly, culture supernatants were clarified by low-speed
entrifugation. The clarified supernatants were centri-
uged at 120,000g for 1 h at 4°C in a Beckman SW 28.1
otor.
xogenous template RT assays
For virus characterization, RT assays were performed
n clarified supernatants as described previously
Gorelick et al., 1990). Exogenous template RT assays
sed in virus isolation experiments were performed as
escribed previously (Benveniste et al., 1986).
iral protein analysis
Virus was harvested as described previously (Gorelick
t al., 1988). Immunoblot analysis was performed as
escribed (Gorelick et al., 1993) using monoclonal anti-
ody to SIV p28CA and rabbit polyclonal antibody to
p120SU. p28CA levels were determined on clarified viral
upernatants using the reagents and protocols from the
etro-Tek SIV-1 Antigen ELISA Kit (Cellular Products,
uffalo, NY).
iral RNA analysis
RNA was isolated as described previously (Fu et al.,
994). Briefly, virus pelleted from 30 ml of culture fluid
as disrupted in 100 ml of sterile buffer containing 50
M Tris buffer, pH 7.4, 100 mM NaCl, 10 mM EDTA,
.0% (w/v) SDS, 50 mg of yeast tRNA/ml (Life Technol-
gies), and 100 mg of Proteinase K/ml (Life Technolo-
ies). Samples were incubated at 37°C for 2–4 h. For
NA blot analysis, samples were extracted twice with
n equal volume of phenol–chloroform–isoamyl alco-
ol (25:24:1, v/v) and then ethanol precipitated. Sam-
les were adjusted for equal levels of particles based
n RT activity before fractionation by denaturing aga-
ose gel electrophoresis, transferred to nitrocellulose
ilters, and hybridized as described previously
Gorelick et al., 1990). The hybridization was per- iormed using an 8.2-kbp DraIII–BglI SIV(Mne) 32P-
abeled probe that was prepared using the DECAprime
I DNA Labeling Kit (Ambion, Austin, TX).
For viral particle RNA genome estimation, the Pro-
einase K-treated samples were ethanol precipitated
nd dried. RNA pellets were dissolved in 0.1 ml of
uffer containing 40 mM Tris–HCl, pH 7.9, 10 mM NaCl,
mM MgCl2, 10 mM CaCl2, and 10 U of RQ1 RNase-
ree DNase (Promega, Madison, Wi) to remove con-
aminating DNA. Samples were incubated at 37°C for
h, and reactions were stopped with the addition of
.0 M guanidine thiocyanate, 0.3 M sodium acetate,
H 6.0, and 0.12 M b-mercaptoethanol. Samples were
thanol precipitated, rinsed with 70% ethanol, dried,
nd resuspended in 50–100 ml of sterile RNase-free
ater containing 400 U of RNASEOUT RNase inhibi-
or/ml (Life Technologies). Real-time RT-PCR for deter-
ining viral RNA levels were performed essentially as
escribed by Suryanarayana et al. (1998). Briefly, in a
ingle reaction, viral RNA is first reverse transcribed,
nd then the cDNA is amplified by PCR using the
ollowing oligonucleotide primers and probe. The for-
ard primer (S-GAG03) has the sequence 59-CAG GGA
II AAG CAG ATG AAT TAG-39, and the reverse primer
S-GAG04) has the sequence 59-GTT TCA CTT TCT
TT CTG CGT G-39. The 59 ends of these oligonucle-
tides correspond to nucleotide positions 558 bp and
18 bp, respectively, in the SIV(Mne) nucleotide se-
uence (GenBank accession no. M32741). The probe,
hich was labeled with 6-carboxyl-fluorescein (FAM)
nd 6-carboxyl-tetramethyl-rhodamine (TAMRA) on the
9 and 39 ends, respectively, has the sequence 59-ATT
GG ATT AGC AGA AAG CCT GTT GGA G-39 (59 end
orresponds to nt position 661 of the SIV(Mne) nucle-
tide sequence). The Applied Biosystems (Foster City,
A) Prism 7700 thermocycler was used for real-time
uantification of cDNA as described previously (Gib-
on et al., 1996; Heid et al., 1991; Suryanarayana et al.,
998).
lectron microscopy
Electron micrographs were performed by K. Na-
ashima (Laboratory of Cell and Molecular Structure,
AIC-Frederick, NCI–FCRDC). The 293T cells transfected
ith mutant and wild-type proviral clones were fixed 48 h
ost-transfection with 1.25% (v/v) glutaraldehyde in PBS.
ell pellets were embedded and processed as de-
cribed previously (Gonda et al., 1976). Embedded cell
ellets were sectioned and examined in a Hitachi H-7000
lectron microscope operated at 75 kV.
n vitro infectivity analysis
Infectivity analysis of transiently expressed virus was
erformed as described previously (Gorelick et al., 1993)
xcept that the CD41 cell line AA2-clone 5 was usednstead of H9 cells. Briefly, 1 ml of fresh mutant or
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269SIV(Mne) NC Zn21-FINGER MUTANTSild-type viral supernatant from each of the 293T trans-
ections was clarified of cells and added to 2 3 106
A2-clone 5 cells in the presence of 2 mg/ml hexad-
methrine bromide. Samples were incubated overnight,
iluted to 10 ml with medium, and cultured over an
-week period. Samples were harvested weekly, and RT
evels were determined and used as an indication of
irus replication.
n vivo infectivity analysis
The SIV(Mne)–DCys33–Cys36 mutant virus, produced
rom transfected 293 cells, was concentrated 10-fold by
entrifugation of virus-containing supernatants in a
eckman Ty50Ti rotor at 35,000 rpm for 100 min, under-
aid with a pad of 20% v/v glycerol, 50 mM Tris–HCl, and
00 mM KCl, pH 7.8. Viral pellets were resuspended in
BS. The mutant particle preparation had an estimated
8 mg of p28CA based on a calibrated immunoblot using
ilutions of purified p28CA (data not shown). Mutant virus
n PBS was injected intravenously into a juvenile pig-
ailed macaque, and the animal was monitored for the
resence of virus and viral DNA sequences as described
reviously (Benveniste et al., 1988, 1994).
CR analysis of pig-tailed macaque PBMC
PBMC were isolated from heparinized whole blood as
escribed previously (Benveniste et al., 1993), and DNA
as extracted according to standard procedures. DNA
350 ng) was used as template for a two-step amplifica-
ion by PCR. A nested set of oligonucleotides specific for
he long terminal repeat regions of SIV(Mne) were used
s primers as described previously (Benveniste et al.,
994).
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